MedTrace Logo

Paclitaxel Eluting Balloon After Bare Metal Stent Implantation vs. Drug-Eluting Stent in St Elevation Myocardial Infarction

NCT03610347 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 199

Last updated 2020-05-26

No results posted yet for this study

Summary

Study objective is the evaluation of safety and efficacy at 12 months of the combination treatment of bare metal Stent plus Paclitaxel Eluting Balloon vs drug eluting stent in patients with ST-elevation myocardial infarction with less than 12 hours of evolution.

Conditions

  • Acute Myocardial Infarction

Interventions

DEVICE

Bare metal Stent plus Paclitaxel Balloon

DEVICE

Drug Eluting Stent

Sponsors & Collaborators

  • Effice Servicios Para la Investigacion S.L.

    collaborator INDUSTRY

  • Fundacion Investigacion Interhospitalaria Cardiovascular

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-29
Primary Completion
2020-01-28
Completion
2020-03-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03610347 on ClinicalTrials.gov